CSPC Pharmaceutical Group Ltd 2021 SR
The report highlights CSPC's commitment to innovation with a mission of 'All for good medicine, all for mankind's health,' investing RMB 3.4 billion in R&D in 2021. Key achievements include the establishment of an mRNA technology platform and significant contributions to COVID-19 relief through drug donations and medical support. The company enhanced its ESG governance by forming a dedicated ESG Team and setting ambitious environmental targets for 2025, including a 50% reduction in greenhouse gas emissions per unit of revenue. Socially, CSPC focused on talent development, employee welfare, and community public welfare through the Hebei CSPC Pu'en Charity Foundation.
Company: CSPC Pharmaceutical Group Ltd
Sector: Health Care
Country: China
Year: 2021
Type: SR
Pages: 71
CSPC Pharmaceutical Group Ltd
The report highlights CSPC's commitment to innovation with a mission of 'All for good medicine, all for mankind's health,' investing RMB 3.4 billion in R&D in 2021. Key achievements include the establishment of an mRNA technology platform and significant contributions to COVID-19 relief through drug donations and medical support. The company enhanced its ESG governance by forming a dedicated ESG Team and setting ambitious environmental targets for 2025, including a 50% reduction in greenhouse gas emissions per unit of revenue. Socially, CSPC focused on talent development, employee welfare, and community public welfare through the Hebei CSPC Pu'en Charity Foundation.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Workplace Fatalities
Employees